Live Oak Health Sciences Fund

Frequently Asked Questions About LOGSX

What does LOGSX invest in?

This fund primarily invests in the common stock of companies operating within the healthcare, medical, or life sciences fields. These businesses are typically involved in the research, development, manufacturing, or distribution of related products and services. Under normal market conditions, a minimum of 80% of the fund's net assets will be dedicated to equity investments in such health science enterprises. While the portfolio's main emphasis is on U.S. company common stocks, it retains the option to a lesser degree to include equity REITs, foreign company shares, and American Depositary Receipts, provided these investments meet the fund's established criteria.

What is the expense ratio of LOGSX?

Live Oak Health Sciences Fund (LOGSX) charges an expense ratio of 1.04%. This is the annual fee deducted from fund assets to cover management and operations.

How big is LOGSX?

Live Oak Health Sciences Fund (LOGSX) manages $52.7M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is LOGSX actively managed or an index fund?

LOGSX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was LOGSX launched?

Live Oak Health Sciences Fund (LOGSX) launched in June 2001 and is managed by the fund issuer.

How has LOGSX performed?

LOGSX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.